ASP 7657

Drug Profile

ASP 7657

Alternative Names: ASP-7657

Latest Information Update: 02 Jul 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Astellas Pharma
  • Class Analgesics; Anti-inflammatories
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Diabetic neuropathies

Most Recent Events

  • 31 May 2015 Discontinued - Phase-I for Diabetic neuropathies (In volunteers) in United Kingdom (PO)
  • 26 Mar 2015 Astellas Pharma terminates a phase I trial in Diabetic nephropathies (In volunteers) in United Kingdom (NCT02108548)
  • 01 Apr 2014 Phase-I clinical trials in Diabetic nephropathies (in volunteers) in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top